Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin continuation vs discontinuation during TURBT
NCT02350543Phase 4Terminated
- Sponsor
- Rabin Medical Center
- Start
- Feb 2015
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of aspirin in cardiovascular disease (CVD), sponsored by Rabin Medical Center. Primary endpoint: Significant hematuria (composite endpoint). Started Feb 2015; status: terminated.
02
Drugs
aspirin
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02350543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02350543.